PASW:NASDAQPing An Biomedical Co., Ltd. Analysis
Data as of 2026-09-01 - not real-time
$0.15
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $0.1516, Ping An Biomedical Co., Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have gained 4.1%. Relative strength is 61.9 — approaching overbought — and the MACD signal is bullish. Watch $0.1200 as support and $0.2400 as the nearer resistance level.
Revenue is contracting at 62.0% on a -37.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 78.3%, a beta of 0.98 and a maximum drawdown of 91.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Revenue is contracting at 62.0% on a -37.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 78.3%, a beta of 0.98 and a maximum drawdown of 91.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
HONG KONG, July 22, 2026 GLOBE NEWSWIRE -- Ping An Biomedical Co.Yahoo Finance1monPing An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500...Enid News & Eagle1monPing An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB .
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.24
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.24
- 30-day volatility of 78.3%
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -37.6%
- Negative return on equity of -67.4%
- Revenue contracting at -62.0%
Key Metrics & Analysis
Financial Health
Revenue Growth-62.00%
Profit Margin-37.57%
ROE-67.43%
ROA-14.67%
Debt/Equity23.14
P/B Ratio0.5
Op. Cash Flow$-6427762
Free Cash Flow$-59241688
Technical Analysis
TrendBearish
RSI61.9
Support$0.12
Resistance$0.24
MA 20$0.13
MA 50$0.14
MA 200$0.24
MACDBullish
VolumeIncreasing
Fear & Greed Index93.07
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta0.98
Volatility78.28%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.